Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Real-world Retrospective Study
16%
Regional Response
16%
Phosphoinositide 3-kinase (PI3K)
16%
SPADE
16%
Pathognomonic
16%
Intralesional Cryosurgery
16%
Extragenital
16%
Nobiletin
16%
Daylight Photodynamic Therapy
16%
Investigational Treatments
16%
TNF Blockade
16%
Histiocytic Necrotizing Lymphadenitis
16%
Epidermal Necrolysis
16%
Cutaneous Lupus Erythematosus
16%
Taiwan
16%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
16%
Citrus Flavonoids
16%
Secukinumab
16%
Single Irradiation
16%
Scleritis
16%
Hidradenitis Suppurativa
16%
Secondary Lymphoma
16%
Epibulbar Tumor
16%
Tetrahydrobiopterin
16%
Anterior Uveitis
16%
Classification Diagnosis
16%
AGS Cells
16%
Hydrochlorothiazide
16%
Small GTPase
16%
Betaxolol
16%
Type 2 Diabetic Patients
16%
Unilateral Blindness
16%
Ophthalmic Artery Occlusion
16%
Hepatitis C Virus Reactivation
16%
Population-based Cohort Study
16%
Emulation Framework
16%
α-mangostin
16%
Human Breast Adenocarcinoma Cells
16%
Erythrokeratodermia Variabilis
16%
Target Trial Emulation
16%
Fisetin
16%
Cataract Surgery
16%
Self-improving
16%
Novel Deletion
16%
Juvenile Xanthogranuloma
16%
Malassezia Folliculitis
16%
Cutaneous Cytomegalovirus
16%
Focal Adhesion Kinase
16%
Diabetic Macular Edema
16%
Human Gastric Adenocarcinoma
16%
Perianal Paget's Disease
16%
Photodermatoses
16%
Glucagon-like peptide-1 (GLP-1)
16%
Retinal Vascular Occlusion
16%
Multi-institutional
16%
Cutaneous Lymphoma
16%
Geographic Ulcer
16%
BH 4
14%
Non-melanoma Skin Cancer
13%
5ARI
12%
Hazard Ratio
12%
Confidence Interval
12%
Corneal Ulcer
11%
PASI Score
9%
A1 Receptor
8%
Herpes Zoster Reactivation
8%
Neuropathic Pain Management
8%
Glucagon-like
8%
Receptor Agonist
8%
Dissecting Cellulitis
7%
Central Centrifugal Cicatricial Alopecia
7%
Facial Nodule
6%
Factor XIIIa
6%
Anorectal Carcinoma
6%
Central Macular Thickness
6%
Fundoscopic Examination
6%
NF-B
6%
CO2 Generation
5%
Accelerated Healing
5%
Ligand Coordination
5%
Metal Ion Ligand
5%
Early Onset Psoriasis
5%
Tissue Flaps
5%
Hydrotherapy
5%
Heterozygous Deletion
5%
16p13.3
5%
Germline DNA
5%
EP300 Gene
5%
Facial Aesthetics
5%
Ophthalmoscopy
5%
Hyaluronic Acid Filler Injection
5%
Causative Variant
5%
Distinctive Facial Features
5%
CREBBP Gene
5%
Viral Polymerase
5%
Fluorescein Staining
5%
Epithelial Keratitis
5%
Acne Keloidalis nuchae
5%
Pseudopelade of Brocq
5%
Scalp Biopsy
5%
Medicine and Dentistry
Cohort Analysis
33%
Meta-Analysis
33%
Hidradenitis Suppurativa
33%
Cutaneous Lymphoma
33%
Diseases
27%
Neoplasm
21%
Biological Product
19%
Retrospective Study
17%
Clinical Feature
17%
Photochemotherapy
16%
Giant Condyloma Acuminatum
16%
Rosai-Dorfman Disease
16%
Dengue Fever
16%
Iridocyclitis
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Subacute Cutaneous Lupus Erythematosus
16%
Scalp
16%
Acneiform Eruption
16%
Hydrochlorothiazide
16%
Maturity Onset Diabetes of the Young
16%
Dermatofibrosarcoma Protuberans
16%
Pathognomonic
16%
Scleritis
16%
Systematic Review
16%
Psoriasis
16%
Ophthalmic Artery
16%
Melanoma
16%
Urticaria
16%
Erythrokeratodermia variabilis
16%
Fisetin
16%
T Cell
16%
Lymphocyte
16%
Cataract Surgery
16%
Phacoemulsification
16%
Juvenile Xanthogranuloma
16%
Malassezia Folliculitis
16%
Lung Cancer
16%
Fibrosis
16%
Dermis
16%
Adjuvant Radiotherapy
16%
Cytomegalovirus Infection
16%
Diabetic Macular Edema
16%
Immunogenetics
16%
Systemic Therapy
16%
Non Melanoma Skin Cancer
13%
Hazard Ratio
13%
Recurrence Risk
12%
Cytomegalovirus
11%
Chlorphenamidine
11%
Diffuse Large B-Cell Lymphoma
11%
Erlotinib
11%
B Cell
11%
Recurrent Disease
10%
Cicatricial Alopecia
9%
Glucagon-Like Peptide-1 Agonist
8%
Biopsy Technique
7%
Radiation Therapy
7%
B-Cell Lymphoma
7%
MALT Lymphoma
7%
Lymphomatoid Papulosis
7%
HLA B13 Antigen
7%
Infection
6%
Podophyllotoxin
6%
Acantholysis
6%
Lip Cancer
6%
Blood Clotting Factor 13a
6%
Histiocytosis
6%
Corneal Ulcer
6%
Lymphoproliferative Disease
5%
T-Cell Lymphoma
5%
Ulcer
5%
Anaplastic Large Cell Lymphoma
5%
Side Effect
5%
Lung Adenocarcinoma
5%
Tyrosine-Kinase Inhibitor
5%
Skin Cancer
5%
Prognostic Factor
5%
Cancer Staging
5%
Lactate Dehydrogenase
5%
Unilateral Blindness
5%
Randomized Controlled Trial
5%
Ophthalmoscopy
5%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Pseudopelade of Brocq
5%
Serum Albumin
5%
Enzyme Linked Immunosorbent Assay
5%
Acne Keloidalis Nuchae
5%
Virus Infection
5%
Brain Metastasis
5%
Disseminated Disease
5%
Endothelial Cell
5%
Mycosis fungoides
5%
B Symptoms
5%
Cell Loss
5%
Proportional Hazards Model
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Non Insulin Dependent Diabetes Mellitus
50%
sodium glucose cotransporter-2 inhibitors
50%
Psoriasis
50%
Biological Product
38%
Secukinumab
33%
Hydrochlorothiazide
33%
Ustekinumab
30%
Skin Cancer
22%
Glucagon Like Peptide 1 Receptor Agonist
18%
Photodynamic Therapy
16%
Receptor Agonist
16%
Sodium Glucose Cotransporter 2 Inhibitor
16%
Glaucoma
16%
Bioflavonoid
16%
Gelatinase B
16%
Sapropterin
16%
Eye Disease
16%
Tumor Necrosis Factor
16%
Hepatitis C Virus
16%
Hepatitis B Virus
16%
12-O-Tetradecanoylphorbol-13-Acetate
16%
Epidermolysis
16%
Betaxolol
16%
Thiazide Diuretic Agent
16%
Immune Checkpoint Inhibitor
16%
Retrospective Study
16%
Breast Adenocarcinoma
16%
Dry Eye
16%
Fisetin
16%
Oxidoreductase
16%
Gelatinase A
16%
Xanthone Derivative
16%
Diabetic Macular Edema
16%
Age Related Macular Degeneration
16%
Antihypertensive
14%
Adalimumab
13%
Non Melanoma Skin Cancer
13%
Tamsulosin
9%
Diuretics
8%
Prostate Hypertrophy
7%
HLA B13 Antigen
7%
Lip Cancer
6%
Basal Cell Carcinoma
6%
Squamous Cell Carcinoma
6%
Stevens Johnson Syndrome
6%
Toxic Epidermal Necrolysis
6%
Dutasteride
5%
Finasteride
5%
Immunoglobulin Enhancer Binding Protein
5%
Remission
5%